Our study therefore reveals a novel mechanism of GCase regulation via LIMP‐2 and uncovers the LIMP‐2 interaction site on GCase as a potential target for therapeutic intervention in GD and PD. The gene discussed is SCARB2; the disease is Parkinson disease.